Second Quarter 2024 Business Update & Financial Results Conference Call July 31, 2024 Aaron Berg CEO & President Tom Reilly CFO Forward Looking Statements & Disclaimer This presentation contains forward-looking statements, such as those relating to the commercial potential of VASCEPA® (VAZKEPA® in Europe), clinical and regulatory efforts and timelines, potential regulatory and pricing approvals, generic product launches,research and development, intellectual property and litigation matters, and other statem ...